Bausch Will Pay $1.2B To End Valeant-Era Stock Suit
Bausch Health Cos. Inc. said Monday it will pay $1.2 billion to resolve a proposed securities class action accusing its former leaders of fraudulently inflating its stock when the Canadian company...To view the full article, register now.
Already a subscriber? Click here to view full article